Efficacy of autologous fat injection laryngoplasty with an adenoviral vector expressing hepatocyte growth factor in a canine model

被引:4
|
作者
Umeno, H. [1 ]
Chitose, S. [1 ]
Murofushi, Y. [3 ]
Kosai, K. [3 ]
Sato, K. [1 ]
Kawahara, A. [2 ]
Nakashima, T. [1 ]
机构
[1] Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kurume, Fukuoka 8300011, Japan
[2] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Div Gene Therapy & Regenerat Med, Dept Neuromusculoskeletal Disorders, Kagoshima 890, Japan
来源
关键词
Autologous Fat Injection Laryngoplasty; Adenoviral Vector; Hepatocyte Growth Factor; Vasculoendothelial Cell; Adipocytes; PARALYSIS;
D O I
10.1017/S0022215109005040
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: The effectiveness of autologous fat injection laryngoplasty may be reduced by resorption of injected fat tissue. The aim of the present study was to clarify the efficacy of fat injection laryngoplasty using autologous fat plus a replication-defective adenoviral vector expressing hepatocyte growth factor, regarding reduction of injected fat tissue resorption. Material and methods: Four female beagle dogs were used in this study. After sedation, a direct laryngoscope was introduced to enable visualisation of the larynx. In each dog, harvested autologous fat plus an adenoviral vector expressing hepatocyte growth factor was injected into the right true vocal fold, and harvested fat plus an adenoviral vector expressing no gene was injected into the left true vocal fold. A total laryngectomy was performed one year after the intracordal fat injection. Coronal sections of the resected whole larynges were made and the following parameters assessed using light and electron microscopy: size of fat area; number of vasculoendothelial cells surrounding adipocytes; and shape of injected adipocytes in the vocal fold. Results: The fat area was significantly larger and the number of vasculoendothelial cells surrounding adipocytes significantly greater in the intracordal fat injection containing adenoviral vector expressing hepatocyte growth factor, compared with the control intracordal fat injection containing adenoviral vector expressing no gene. When viewed under electron microscopy, the injected adipocytes were observed to have grafted better in the intracordal fat injection with hepatocyte growth factor adenoviral vector, compared with the control intracordal fat injection with adenoviral vector expressing no gene. Conclusions: Injection into the vocal fold of autologous fat containing an adenoviral vector expressing hepatocyte growth factor can reduce subsequent resorption of injected fat.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 50 条
  • [1] Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice
    Gao, CH
    Jokerst, R
    Gondipalli, P
    Cai, SR
    Kennedy, S
    Ponder, KP
    HUMAN GENE THERAPY, 1999, 10 (06) : 911 - 922
  • [2] Muscle injection of an adenoviral vector expressing hepatocyte growth factor induces hepatocyte replication and facilitates hepatic gene therapy with a retroviral vector.
    Gao, G
    Sands, M
    Kennedy, S
    Jokerst, R
    Gondipalli, P
    Ponder, KP
    HEPATOLOGY, 1998, 28 (04) : 237A - 237A
  • [3] Adenoviral vector expressing hepatocyte growth factor promotes liver regeneration by preoperative injection: The advantages of performing selective injection to the remnant lobe
    Ueno, Masaki
    Uchiyama, Kazuhisa
    Nakamori, Mikihito
    Ueda, Kentaro
    Iwahashi, Makoto
    Ozawa, Satoru
    Yamaue, Hiroki
    SURGERY, 2007, 141 (04) : 511 - 519
  • [4] Post-infarct injection of an adenoviral vector expressing hepatocyte growth factor into skeletal muscle relieves ventricular remodeling and heart failure in mice
    Li, YW
    Takemura, G
    Hayakawa, K
    Kasai, K
    Nagano, S
    Yuge, K
    Esaki, M
    Koda, M
    Kawase, Y
    Maruyama, R
    Fujiwara, T
    Fujiwara, H
    CIRCULATION, 2002, 106 (19) : 30 - 31
  • [5] Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice
    Li, YW
    Takemura, G
    Kosai, K
    Yuge, K
    Nagano, S
    Esaki, M
    Goto, K
    Takahashi, T
    Hayakawa, K
    Koda, M
    Kawase, Y
    Maruyama, R
    Okada, H
    Minatoguchi, S
    Mizuguchi, H
    Fujiwara, T
    Fujiwara, H
    CIRCULATION, 2003, 107 (19) : 2499 - 2506
  • [6] Efficacy and safety of therapeutic angiogenesis from direct myocardial administration of an adenoviral vector expressing vascular endothelial growth factor 165
    Zhang, DZ
    Gai, LY
    Fan, RY
    Dong, W
    Wen, YF
    CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 643 - 648
  • [7] Efficacy of hepatocyte growth factor as angiogenic factor in comparison with vascular endothelial growth factor in ischemic canine heart
    Funatsu, T
    Sawa, Y
    Fukushima, N
    Takahashi, T
    Matsumiya, G
    Matsuda, H
    CIRCULATION, 2001, 104 (17) : 253 - 253
  • [8] Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor
    Magovern, CJ
    Mack, CA
    Zhang, J
    Rosengart, TK
    Isom, OW
    Crystal, RG
    HUMAN GENE THERAPY, 1997, 8 (02) : 215 - 227
  • [9] Influence of hepatocyte growth factor on autologous osteochondral transplants in an animal model
    Carsten O. Tibesku
    Kiriakos Daniilidis
    T. Szuwart
    U. R. Jahn
    P. M. Schlegel
    S. Fuchs-Winkelmann
    Archives of Orthopaedic and Trauma Surgery, 2011, 131 : 1145 - 1151
  • [10] Influence of hepatocyte growth factor on autologous osteochondral transplants in an animal model
    Tibesku, Carsten O.
    Daniilidis, Kiriakos
    Szuwart, T.
    Jahn, U. R.
    Schlegel, P. M.
    Fuchs-Winkelmann, S.
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2011, 131 (08) : 1145 - 1151